The Readout Loud

A podcast by STAT - Thursdays

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

Sponsored
Thursdays

Categories:

Business

324 Episodes

  1. 321: Summit's upcoming cancer results, Recursion's mixed data, and the next big obesity target

    Published: 05/09/2024

  2. 320: Jim Wilson's next venture, a surprise startup shutdown, & Lilly's Zepbound strategy

    Published: 29/08/2024

  3. From "Say More": What Happens When AI Decides Your Medical Coverage

    Published: 23/08/2024

  4. 319: BioMarin's executive shakeup, a GLP-1 lowers diabetes risk, and a deep look at Recursion's AI bona fides

    Published: 22/08/2024

  5. 318: Drug pricing drops & psychedelics under fire

    Published: 15/08/2024

  6. 317: VC struggles, drug pricing negotiations, & Novo's abrupt Wegovy decision

    Published: 08/08/2024

  7. 316: The long journey to make malaria vaccines, and Sarepta's ties with patient advocates

    Published: 01/08/2024

  8. 315: UnitedHealth's doctor empire, an FDA departure, and Viking's obesity moves

    Published: 25/07/2024

  9. 314: JD Vance's biotech ties, Cassava resignations, and insulin shortages

    Published: 18/07/2024

  10. 313: Biotech layoffs, founder-focused VC, & a big pharma exit

    Published: 11/07/2024

  11. 312: Medicare coverage for GLP-1 drugs, AI, and health care at the presidential debate

    Published: 27/06/2024

  12. 311: Fauci's memoir, Alnylam's tenuous trial, and a mid-year review

    Published: 20/06/2024

  13. 310: Duchenne gene therapy setback, Alzheimer's drug endorsement & why a STAT reporter buys weed (for journalism)

    Published: 13/06/2024

  14. 309: Psychedelics at the FDA, ASCO recap, & MorphoSys update

    Published: 06/06/2024

  15. 308: An ASCO preview & another Duchenne trial failure

    Published: 30/05/2024

  16. 307: More tumult at BIO & coercive care for sickle cell patients

    Published: 23/05/2024

  17. 306: Live! From the STAT Breakthrough Summit West

    Published: 16/05/2024

  18. 305: Everything you need to know about H5N1 bird flu

    Published: 09/05/2024

  19. 304: Controversial brain tissue research, obesity drug sales and Novartis’ M&A drama

    Published: 02/05/2024

  20. 303: A new obesity startup, an acquisition gone wrong, & the future of Teledoc

    Published: 18/04/2024

1 / 17

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Visit the podcast's native language site